While the evidence for Group 2A agents might not be as strong as that for Group 1 carcinogens, understanding and recognizing these potential risks is crucial for public health. Avoiding or reducing exposure to these substances can be a proactive approach to minimizing cancer risks where possible. Public awareness and regulatory measures can help mitigate exposure to such probable carcinogens.
